| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $80.0M | -68.0% |
| R&D Expense | $127.4M | +38.2% |
| SG&A Expense | $35.9M | +0.3% |
| Operating Income | -$83.3M | -168.3% |
| Pre-tax Income | -$64.3M | -148.1% |
| Income Tax | $665K | -52.8% |
| Net Income | -$65.0M | -149.1% |
| EPS (Basic) | -$1.13 | -136.7% |
| EPS (Diluted) | -$1.13 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.4M | +3.7% |
| Short-term Investments | $195.3M | +20.5% |
| Accounts Receivable | $1.5M | -98.1% |
| Current Assets | $276.8M | -13.4% |
| Total Assets | $393.1M | +11.9% |
| Current Liabilities | $49.8M | -22.8% |
| Total Liabilities | $93.3M | -18.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | -119.6% |
| Capital Expenditures | $3.5M | +8.1% |
| Investing Cash Flow | -$94.9M | +33.0% |
| Financing Cash Flow | $114.0M | +238.9% |
| Free Cash Flow | -$18.8M | -125.2% |
| -138.0% |
| Stockholders' Equity |
| $299.8M |
| +26.8% |